Medical Cannabis

 is a Princeton, New Jersey-based psychiatrist, writer, speaker, educator, and consultant. He is the founder and board president of Doctors for Cannabis Regulation. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. He serves on the editorial board of 

Articles

Working with Doctors for Cannabis Regulation and other stakeholders, David L. Nathan, MD, proposed the Universal Cannabis Product Symbol (UCPS) in 2019. After its publication in 2020, a broad discussion with various stakeholders led to a series of changes to the UCPS. Working with the standards organization ASTM, the authors of this paper co-designed a modified version of the UCPS, which was renamed the International Intoxicating Cannabis Product Symbol (IICPS). This article presents the IICPS and next steps for the industry to start implementing its use.

Why All Legalized U.S. Jurisdictions Should (and Probably Will) Adopt the International Intoxicating Cannabis Product Symbol (IICPS)


The Massachusetts Cannabis Control Commission recently announced several appointments so their Cannabis Advisory Board, the members of which will study and make recommendations to the Commission regarding the regulation and taxation of marijuana in the state.

Massachusetts Cannabis Advisory Board Appointees Announced by Treasurer Goldberg

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


Dr. Denise Vidot shares some of her research findings that examine the impact of phytocannabinoids on multiple diseases.

Exploring the Impact of Cannabis on the Human Brain, Heart, and Gut

In this piece, we touch on the benefits and challenges associated with autoflowering genetics, and provide justification for why these unique varietals may be the catalyst for making cannabis medicine more accessible and approachable for the general population. 

Autoflowering Genetics Present Unique Opportunities

Medical cannabis patients and adult-use consumers alike are faced with an overwhelming amount of options when they first enter a dispensary. Across the industry, producers are looking for ways to simplify things for consumers. One company, Volunteer Botanicals, recently partnered with an investment group to create cannabidiol (CBD)-based tablets that also combine other cannabinoids and have the potential to create a unique consumer experience. In this interview, Jason Pickle, co-founder and chief sales officer for Volunteer Botanicals, sits down to discuss this recent product, the need for standardization throughout the cannabis industry, and more.

How the Cannabis Market Can Expand with Innovative Products Like CBD Instant Release Tablets

Society’s ability to treat medical conditions is intimately tied to the extent of its knowledge and use of science and technology. No doubt, we’ve come a long way over the millennia. On the other hand, we still have so far to go.

Transitioning to 21st Century Medicine: The Promise of Whole Plant Medicine

The partnership will focus on sharing patient and advocate experiences and educating the public on the medical benefits of cannabis.

Cannabis Patient Care™ and Americans for Safe Access Form Partnership

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth  have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth

In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila’s research efforts to document her case and help the lives of other cancer patients.

Medical Cannabis as an Adjunct Therapy to  Cancer Treatment: One Patient’s Journey from Diagnosis to Remission

Congress passes the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act and the Medical Marijuana Research Act in two historic votes, signifying a growing shift toward cannabis legalization.